Cao B

Key Laboratory of Cognition and Personality, Faculty of Psychology, Ministry of Education, Southwest University, Chongqing, 400715, PR China.

16 papers · ORCID

ArticleKetamine

Cognitive effects of ketamine and esketamine treatment for major depressive and bipolar disorder: a systematic review.

Xiao K, Woo Y, Dri CE +12

Europe PMC2026
ArticleMDMA

Investigating the impact of serotonergic psychedelic drugs, MDMA and ketamine on social cognition in psychiatric disorders: A scoping review.

Smith SA, Mohammad H, Lee LHN +13

Europe PMC2026
ArticleKetamine

Effect of ketamine on reward processing in depressive disorders: a systematic review of neuroimaging studies.

Faisal H, Le GH, Kwan ATH +10

Europe PMC2026
ArticleKetamine

Is the antidepressant efficacy of ketamine and esketamine mediated via opioid mechanisms?

Lu A, Xu H, Le GH +9

Europe PMC2026
ArticlePsilocybin

Systematic study of <i>Panaeolus</i> (<i>Agaricales</i>, <i>Galeropsidaceae</i>) sensu lato and psilocybin-producing traits of species from China.

He MQ, Yang WQ, Phurbu D +4

Europe PMC2026
ArticleKetamine

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review.

Yin L, Lu A, Le GH +13

Europe PMC2026
ArticleKetamine

A Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBase.

Kwan ATH, Lakhani M, Rosenblat JD +8

Europe PMC2025
ArticleKetamine

Should glutamatergic modulators be considered preferential treatments for adults with major depressive disorder and a reported history of trauma? Conceptual and clinical implications.

Teopiz KM, Lo HKY, Lakhani M +11

Europe PMC2025
ArticleKetamine

Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysis.

Kwan ATH, Lakhani M, Teopiz KM +8

Europe PMC2025
ArticleKetamine

A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists.

Kwan ATH, Rosenblat JD, Mansur RB +7

Europe PMC2024
ArticlePsilocybin

Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.

Yu Z, Burback L, Winkler O +11

Europe PMC2024
ArticleKetamine

Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis.

Calder CN, Kwan ATH, Teopiz KM +7

Europe PMC2024
ArticlePsilocybin

A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.

Wong S, Kwan ATH, Teopiz KM +8

Europe PMC2024
ArticleKetamine

Esketamine use is associated with shortened postoperative hospital stay in patients after knee arthroscopic surgery: a propensity score-matched cohort study.

Liu J, Han H, Yang S +3

Europe PMC2024
ArticlePsilocybin

A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.

Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F +14

Europe PMC2022
ArticlePsychedelics

An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress.

Lu J, Tjia M, Mullen B +8

Europe PMC2021